Donation Amount. Min £2

Health

The new operation carries a risk of serious side-effects, such as infection, erectile dysfunction and urinary problems.Credit: PA
BY ITV

A ground-breaking trial of a prostate cancer treatment with fewer side effects has begun in the UK, researchers have announced.

Backed by the Government-funded National Institute for Health and Care Research (NIHR), the trial will examine whether Aquablation – a therapy using robotics, AI and real-time imaging – works as well or better than traditional surgery, known as radical prostatectomy.

With radical prostatectomy, the entire prostate gland is removed in a bid to cure men of prostate cancer.

The treatment is suitable for men whose cancer has not spread outside of the prostate gland or has spread to the area just outside the gland.

However, the operation carries a risk of serious side-effects, such as infection, erectile dysfunction and urinary problems.

With Aquablation, experts hope to minimise these issues.

The therapy is currently used in some centres to treat benign prostatic hyperplasia (BPH).

Aquablation involves a robotic-assisted, high-pressure waterjet. Surgeons can also map the entire prostate in real time with ultrasound.

Using the technique, medics find cancerous tissue to remove while avoiding surrounding nerves and muscles associated with erectile function and the bladder.

The Royal Marsden NHS Foundation Trust in London is the first hospital in Europe to recruit a patient to the trial, which is being run in seven countries.

Overall, 280 patients will be recruited globally, all with early-stage, localised prostate cancer who have already decided to have surgery.

A doctor consulting a male patient using a pen to point at a reproductive system model
The entire prostate gland is removed with radical prostatectomy.Credit: PA

Philip Charlesworth, consultant urological surgeon at the Royal Marsden, said: “For men with prostate cancer confined to the prostate, curative options are excellent; however, we are becoming increasingly focused on the side-effects of the cancer treatment and how we can embrace new technology to maintain a man’s quality-of-life following their surgery.

“This trial is measuring Aquablation therapy, which uses a robotic approach to surgically remove the cancer, and to preserve a man’s ability to remain continent and maintain sexual activity.

“The potential for this trial is very exciting. It has an opportunity, depending on the results of the study, to add an alternative surgical treatment option for patients with localised prostate cancer across the globe.

“The ultimate aim, and my passion, is to improve prostate cancer treatments so that they cause less harm and are less invasive for the patient.

“I feel that this is an incredibly exciting prospect for the future of prostate cancer care.”

The Royal Marsden Hospital
The Royal Marsden NHS Foundation Trust is the first hospital in Europe to recruit a patient to the trial.Credit: PA

Other potential treatments for localised prostate cancer include active surveillance or monitoring of the cancer and radiation.

The new trial is sponsored by US company Procept BioRobotics.

To date, there are more than 25 centres globally recruiting patients for the trial.

The four UK centres are the Royal Marsden, Guy’s and St Thomas’ NHS Foundation Trust, the Royal Free London NHS Foundation Trust and Norfolk and Norwich University Hospitals NHS Foundation Trust.

The trial comes after Health Secretary Wes Streeting said earlier this week he was “surprised” by the decision from scientific advisers to limit prostate cancer screening.

In a draft recommendation, the UK National Screening Committee (UKNSC), which advises the Government, said prostate cancer screening should not be made routinely available for the vast majority of men in the UK.

It said it would not recommend population screening using the prostate-specific antigen (PSA) test because it “is likely to cause more harm than good”.

Wes Streeting
Health Secretary Wes Streeting said he was surprised by the decision to limit prostate cancer screening.Credit: PA

Experts are expecting data within two years from a large trial launched by Prostate Cancer UK into whether combining PSA with other tests, such as rapid MRI scans, could lead to a recommendation for population-wide screening.

For now, the committee will put forward only a recommendation to screen men with BRCA1 and BRCA2 genetic mutations, which puts them at far higher risk of prostate cancer, every two years, between the ages of 45 and 61.

Speaking on Wednesday on BBC Breakfast, Streeting said he was surprised by the decision.

He said: “I’m looking very carefully at why the national screening committee reached that decision.

“I’ve always said these things have got to be based on science and evidence, not on politics.

“But the recommendation did surprise me.

“This is contested. I’ve got people in the prostate cancer community and not just really prominent patients and celebrities and politicians who’ve used their experience and their voice in this debate, but among scientists and researchers.

Sir Chris Hoy
Sir Chris Hoy, who has prostate cancer, has expressed disappointment with the screening committee decision.Credit: PA

“This is a draft recommendation. They consult on this for three months, and then we have to make a final decision.

“What I’m going to do is get some of those leading, best scientific voices and competing opinions around the table to thrash this out, to really interrogate the data and make sure that when I come on your programme having made a decision, it’s the right decision for the right reasons, the best evidence and the public can then understand why we’ve made the decision and the scientific community can understand why we’ve made the decision.

“But I am interrogating this data and recommendation because it did surprise me.”

Many experts argue that the PSA test is not very reliable because men with a high PSA level may not have cancer, and some men with cancer have a normal PSA result.

A positive test result may lead to unnecessary treatment for slow-growing or harmless tumours, leaving men at risk of side effects such as incontinence and erectile dysfunction. But others argue that current evidence supports wider testing.

University of the Witwatersrand - Edson Mwebesa, Fellow at the Wits-based Sub-Saharan Africa Advanced Consortium for Biostatistics (SSACAB), knows children who died from late-diagnosed malaria. His research has also revealed that malaria is more prevalent in pregnant Ugandan women than in any other population. Malaria is also endemic across Africa, impacting all aspects of social and economic life.

Mwebesa, a biostatistician, wanted to dive deeper into what made people choose methods to help prevent malaria. He focused on social and behavioral change messaging, an essential part of encouraging people to use insecticide-treated nets (ITNs). While messaging campaigns have been implemented in the media, hospitals, and schools, the question of whether these messages actually change behavior remains uncertain. Robust biostatistics methods used by African experts are set to change this 

Mwebesa applied a quasi-experimental causal inference method, known as Propensity Score Matching, to investigate this phenomenon. This approach can measure, with precision, whether messaging actually changes behavior.

Traditionally, measuring messaging impact relied on simple correlations and on counting how many people heard a message and whether they used a mosquito bed net. But correlation cannot reveal whether the messages caused the behavior, which in this case is using the mosquito net. Those who heard or saw the messages might differ from those who did not, and thus, the use of mosquito nets might not be comparable between these groups.

Those who hear malaria messages are often wealthier, more educated, or better connected, and these factors independently increase bed net use. This has made it difficult for policymakers to know whether expensive behavior-change campaigns genuinely deliver impact.

Mwebesa measured the impact of messaging aimed at women in Uganda. In that country, about one in four children under five years old tested positive for malaria. In some districts, incidence rates over six-month periods have exceeded 500 cases per 1000 people, demonstrating how quickly the disease can spread in high-transmission settings. Malaria causes fever, chills, weakness, anaemia, and in some cases, complications involving the brain, lungs and other organs. Beyond the clinical burden, malaria disrupts schooling, reduces productivity and places immense strain on household finances, particularly among poorer families.

Understanding how to drive preventive behavior in this context is both a scientific and operational priority. Historically, however, researchers lacked the tools and data required to measure the impact of health communication. In 2001, economists John Luke Gallup and Jeffrey Sachs, writing in The Intolerable Burden of Malaria, explained that reliable data on malaria incidence were lacking for many of the most severely affected countries.

They constructed an indirect malaria index using historical risk maps, estimates of the proportion of falciparum malaria and population distribution data. Their work was pioneering but constrained by limited information, underscoring how weak data systems restricted the ability to study malaria's economic and social effects. They could not measure behavior or the effectiveness of prevention campaigns. They could only infer risk.

We're in a different position now. We have conducted repeated Malaria Indicator Surveys, geocoded demographic data, collected extensive health record data, and improved surveillance systems. What's most exciting, though, is how we are growing the capacity to analyse data using modern causal methods." 

Edson Mwebesa, Fellow at the Wits-based Sub-Saharan Africa Advanced Consortium for Biostatistics

Institutions such as SSACAB have trained a new generation of African biostatisticians who can use advanced techniques to answer complex policy questions that were previously out of reach.

Mwebesa used nationally representative data from the 2018–19 Malaria Indicator Survey and examined whether exposure to malaria messages increases the use of insecticide-treated nets among women of reproductive age and children under five in Uganda. The descriptive findings show that 37.6 per cent of women aged 15–49 and 37.9 per cent of caregivers of young children had been exposed to malaria prevention messages in the six months preceding the survey. Net use was higher but not universal: 69.3 per cent of women reported sleeping under an insecticide-treated net the night before the survey, as did 71.8 per cent of children under five.

Mwebesa's use of propensity score matching paired each woman who was exposed to malaria messages with another woman who was not, but who shared similar characteristics, such as age, education level, wealth, household size, region, and urban or rural residence. By ensuring that the two groups are comparable, the method isolates the effect of the messaging itself.

"For years, people assumed that malaria messages influenced behaviour, but this analysis shows, with causal evidence, exactly how much they matter. Our findings demonstrate that communication increases net use. We can now quantify this," he said.

After matching, women who were exposed to malaria messages were 5.1 percent more likely to sleep under an insecticide-treated net than similar women who were not exposed. Among children, caregivers' exposure to messages increased ITN use by 4.3 percent.

These differences, when applied nationally, translate into tens of thousands of additional protected households and reduced malaria direct and indirect costs. The study also identified which communication channels were major sources of malaria messages. Radio emerged as the dominant messaging channel, reaching roughly two-thirds of women and caregivers. Community health workers and interpersonal communication were also influential. Digital platforms were used far less frequently, suggesting an untapped potential.

Professor Tobias Chirwa, Principal Investigator for SSACAB and Head of the Wits School of Public Health, explains why this type of work matters for Africa's statistical future. "This study shows what becomes possible when we combine strong African data with strong African statistical capacity. We move from describing problems to measuring impact. That is the essence of statistical innovation. African biostatisticians are leading analyses that were impossible twenty years ago."

In light of African Statistics Day, this work reflects an important shift in statistical justice and evidence sovereignty. Africa is no longer dependent on global assumptions or incomplete models. It can produce high-quality causal evidence that speaks to households' lived realities and informs local policy with accuracy and confidence. This, in turn, supports more efficient investments in communication campaigns, builds equity by identifying which groups are least reached and strengthens the effectiveness of malaria prevention efforts across the continent.

African Statistics Day 2025 highlights the theme of leveraging innovations in data and statistics to promote a just, peaceful, inclusive and prosperous society for Africans. In the field of malaria prevention, this theme is particularly resonant. Source: News Medical Life Sciences

 

By Asha Bekidusa, Photo Courtesy Willow Health Media 

Unlike conventional medicine that treats symptoms, Ayurveda focuses on root causes of disease and views health as a balance between body, mind and spirit. 

Rosemary Odinga, daughter of the late former Kenyan Prime Minister Raila Odinga, lost her sight after brain tumour surgery and a stroke in 2017. After conventional treatments in multiple countries failed, her family turned to an ancient Indian healing system called Ayurveda. 

After conventional treatments in multiple countries failed, her family turned to an ancient Indian healing system called Ayurveda. 

At Sreedhareeyam Ayurvedic Eye Hospital in Kerala, India, Rosemary received traditional therapies for secondary optic atrophy, a condition causing vision loss.

Within four months, her sight began returning. By 2022, her recovery was described as miraculous, reigniting global interest in Ayurvedic medicine.  

Raila, it has emerged, had been suffering from multiple conditions including diabetes, high blood pressure, Deep Vein Thrombosis, brain bleed and chronic kidney disease.

He was undergoing Ayurveda treatment before a cardiac arrest from which he did not recover on October 15. He was 80.

So, what is Ayurveda? 

Ayurveda means ‘the science of life’ from the Sanskrit (Ayur = life, Veda = knowledge). It is one of the world’s oldest medical systems, originating in India over 5,000 years ago. 

Unlike conventional medicine that treats symptoms, Ayurveda focuses on the root causes of disease. It views health as a balance between body, mind, and spirit.  

Ayurveda developed alongside ancient Hindu philosophical schools that emphasised observation, logic, and reasoning. It views the human body as part of the natural universe, made from the same elements. 

Ayurveda views health as a state of balance among three biological energies, or The Three Doshas: 

  • Vata (air and space) 
  • Pitta (fire and water) 
  • Kapha (water and earth) 

When these energies are balanced, you’re healthy. When disturbed, disease occurs. 

Ayurvedic Eye Treatment (Netra Chikitsa) 

In Ayurveda, eyes are “windows to the soul” and mirrors of internal health. Vision problems aren’t just eye issues; they reflect imbalances in your entire system. 

Common Ayurvedic Eye Therapies 

  1. Netra Tarpana: Eye bath using medicated ghee (clarified butter) to strengthen optic nerves and improve vision clarity 
  2. Nasya: Herbal oils administered through the nasal passages to cleanse the head and enhance oxygen flow to the eyes 
  3. Netra Sekam: Continuous pouring of herbal solutions over the eyes to reduce inflammation and remove impurities 
  4. Snehana and Swedana: Oil massage and steam therapy to improve blood circulation and eliminate toxins 

How It Differs from Conventional Treatment 

Ayurvedic Approach: 

  • Treats underlying energy imbalances 
  • Uses herbal formulations, ghee therapies, and detoxification 
  • Includes diet and lifestyle corrections 
  • Aims to restore natural eye function by reviving damaged tissues 

Conventional Approach: 

  • Treats specific symptoms or defects 
  • Uses surgery, corrective lenses, laser therapy, and pharmaceuticals 
  • Focuses on mechanical correction 

Global Recognition and Acceptance 

The World Health Organization (WHO) recognises Ayurveda as a legitimate traditional medical system and encourages countries to integrate it into public healthcare. 

According to the WHO’s 2019 report: 

  • 170 countries use some form of traditional medicine 
  • About 40% of modern pharmaceuticals trace their roots to traditional herbal knowledge (including aspirin and artemisinin) 

Africa a growing market for Indian medicines 

Ayurvedic medicine has entered Africa through trade and the growing market for Indian-based medicines. South Africa officially recognises it, and it complements Africa’s strong tradition of indigenous herbal medicine. 

In Kenya, Ayurvedic clinics operate in cities like Nairobi. Some insurance providers now partner with Ayurvedic institutions to cover alternative treatments. Kenya’s National Drug Policy (1994) and Development Plan (1989) acknowledge the value of traditional medicine. 

Several global figures have embraced Ayurvedic therapies for their rejuvenation and stress relief, including; 

  • Supermodel Naomi Campbell (massage treatments in Kerala, 2013) 
  • Pop star Madonna 
  • Former UK Prime Minister Tony Blair and wife, Cherie Blair 

The Future of Ayurveda 

As modern science increasingly validates traditional knowledge, Ayurveda sits at the intersection of ancient wisdom and modern innovation. The convergence of traditional systems- Ayurveda, Chinese medicine, naturopathy – may open new doors in: 

  • Herbal drug discovery 
  • Preventive health 
  • Integrative medical education 

Raila Odinga’s choice of Ayurveda for his daughter wasn’t just a desperate attempt; it was a testament to faith in humanity’s oldest healing science. His own subsequent treatment in India demonstrates how this ancient system remains valued today for its use of natural elements. 

As the 21st century embraces wellness, balance, and sustainability, Ayurvedic medicine is poised to help shape the future of healthcare. 

Key takeaway 

Ayurveda offers a holistic approach to health that treats the person as a whole, body, mind, and spirit, rather than just addressing isolated symptoms. While it shouldn’t replace conventional medicine in emergencies, it provides complementary options that have helped patients like Rosemary Odinga when other treatments failed.  

This article was first published by Willow Health Media on October 16, 2025.

About IEA Media Ltd

Informer East Africa is a UK based diaspora Newspaper. It is a unique platform connecting East Africans at home and abroad through news dissemination. It is a forum to learn together, grow together and get entertained at the same time.

To advertise events or products, get in touch by info [at] informereastafrica [dot] com or call +447957636854.
If you have an issue or a story, get in touch with the editor through editor[at] informereastafrica [dot] com or call +447886544135.

We also accept donations from our supporters. Please click on "donate". Your donations will go along way in supporting the newspaper.

Get in touch

Our Offices

London, UK
+44 7886 544135
editor (@) informereastafrica.com
Slough, UK
+44 7957 636854
info (@) informereastafrica.com

Latest News

UK Anti-Corruption Strategy: Ambitious plan undermined by political integrity gaps

UK Anti-Corruption S...

Transparency International UK has welcomed the government's new Anti-Corruption Strategy [1] as its...

Donald Trump suggests Netflix’s takeover of Warner Bros. may “be a problem”

Donald Trump suggest...

"I'll be involved in that decision," the US president said Donald Trump. CREDIT: Getty/Chip Somodevi...

Kenya, UK boost health partnership in new deal

Kenya, UK boost heal...

The collaboration aims to upgrade Kenya’s readiness for emerging health threats and expand innovatio...

Tanzania urges non-essential workers to remain home Independence Day

Tanzania urges non-e...

Tanzania's President Samia Suluhu during the campaign period before the General Election. Photo/Sulu...

For Advertisement

Big Reach

Informer East Africa is one platform for all people. It is a platform where you find so many professionals under one umbrella serving the African communities together.

Very Flexible

We exist to inform you, hear from you and connect you with what is happening around you. We do this professionally and timely as we endeavour to capture all that you should never miss. Informer East Africa is simply news for right now and the future.

Quality News

We only bring to you news that is verified, checked and follows strict journalistic guidelines and standards. We believe in 1. Objective coverage, 2. Impartiality and 3. Fair play.

Banner & Video Ads

A banner & video advertisement from our sponsors will show up every once in a while. It keeps us and our writers coffee replenished.